These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32510717)

  • 1. Securinine suppresses osteoclastogenesis and ameliorates inflammatory bone loss.
    Kwak SC; Jeong DH; Cheon YH; Lee CH; Yoon KH; Kim JY; Lee MS
    Phytother Res; 2020 Nov; 34(11):3029-3040. PubMed ID: 32510717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Inflammatory and Neuroprotective Role of Natural Product Securinine in Activated Glial Cells: Implications for Parkinson's Disease.
    Leonoudakis D; Rane A; Angeli S; Lithgow GJ; Andersen JK; Chinta SJ
    Mediators Inflamm; 2017; 2017():8302636. PubMed ID: 28473732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Securinine induces mitotic block in cancer cells by binding to tubulin and inhibiting microtubule assembly: A possible mechanistic basis for its anticancer activity.
    Ashraf SM; Mahanty S; Rathinasamy K
    Life Sci; 2021 Dec; 287():120105. PubMed ID: 34756929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flueggeacosines A-C, Dimeric Securinine-Type Alkaloid Analogues with Neuronal Differentiation Activity from Flueggea suffruticosa.
    Wu ZL; Huang XJ; Xu MT; Ma X; Li L; Shi L; Wang WJ; Jiang RW; Ye WC; Wang Y
    Org Lett; 2018 Dec; 20(23):7703-7707. PubMed ID: 30484660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethanol extract of Polyscias fruticosa leaves suppresses RANKL-mediated osteoclastogenesis in vitro and LPS-induced bone loss in vivo.
    Tran PT; Dang NH; Kim O; Van Cuong P; Dat NT; Hwangbo C; Van Minh C; Lee JH
    Phytomedicine; 2019 Jun; 59():152908. PubMed ID: 30981187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Securinine inhibits the tumor growth of human bladder cancer cells by suppressing Wnt/β-catenin signaling pathway and activating p38 and JNK signaling pathways.
    Xie L; Liang S; Jiwa H; Zhang L; Lu Q; Wang X; Luo L; Xia H; Li Z; Wang J; Luo X; Luo J
    Biochem Pharmacol; 2024 May; 223():116125. PubMed ID: 38484850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Securinine, a myeloid differentiation agent with therapeutic potential for AML.
    Gupta K; Chakrabarti A; Rana S; Ramdeo R; Roth BL; Agarwal ML; Tse W; Agarwal MK; Wald DN
    PLoS One; 2011; 6(6):e21203. PubMed ID: 21731671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ganomycin I from Ganoderma lucidum attenuates RANKL-mediated osteoclastogenesis by inhibiting MAPKs and NFATc1.
    Tran PT; Dat NT; Dang NH; Van Cuong P; Lee S; Hwangbo C; Van Minh C; Lee JH
    Phytomedicine; 2019 Mar; 55():1-8. PubMed ID: 30668419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alisol-B, a novel phyto-steroid, suppresses the RANKL-induced osteoclast formation and prevents bone loss in mice.
    Lee JW; Kobayashi Y; Nakamichi Y; Udagawa N; Takahashi N; Im NK; Seo HJ; Jeon WB; Yonezawa T; Cha BY; Woo JT
    Biochem Pharmacol; 2010 Aug; 80(3):352-61. PubMed ID: 20412788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sanguiin H-6, a constituent of Rubus parvifolius L., inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis and bone resorption in vitro and prevents tumor necrosis factor-α-induced osteoclast formation in vivo.
    Sakai E; Aoki Y; Yoshimatsu M; Nishishita K; Iwatake M; Fukuma Y; Okamoto K; Tanaka T; Tsukuba T
    Phytomedicine; 2016 Jul; 23(8):828-37. PubMed ID: 27288918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Umbelliferone Prevents Lipopolysaccharide-Induced Bone Loss and Suppresses RANKL-Induced Osteoclastogenesis by Attenuating Akt-c-Fos-NFATc1 Signaling.
    Kwak SC; Baek JM; Lee CH; Yoon KH; Lee MS; Kim JY
    Int J Biol Sci; 2019; 15(11):2427-2437. PubMed ID: 31595160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kirenol inhibits RANKL-induced osteoclastogenesis and prevents ovariectomized-induced osteoporosis via suppressing the Ca
    Zou B; Zheng J; Deng W; Tan Y; Jie L; Qu Y; Yang Q; Ke M; Ding Z; Chen Y; Yu Q; Li X
    Phytomedicine; 2021 Jan; 80():153377. PubMed ID: 33126167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-securinine induces apoptosis in the human promyelocytic leukemia cell line HL-60 and influences the expression of genes involved in the PI3K/AKT/mTOR signaling pathway.
    Han S; Zhang G; Li M; Chen D; Wang Y; Ye W; Ji Z
    Oncol Rep; 2014 May; 31(5):2245-51. PubMed ID: 24676995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiproliferative activity and apoptosis-inducing mechanism of L-securinine on human breast cancer MCF-7 cells.
    Li M; Han S; Zhang G; Wang Y; Ji Z
    Pharmazie; 2014 Mar; 69(3):217-23. PubMed ID: 24716413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
    Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
    Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Securinine disturbs redox homeostasis and elicits oxidative stress-mediated apoptosis via targeting thioredoxin reductase.
    Zhang J; Yao J; Peng S; Li X; Fang J
    Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):129-138. PubMed ID: 27777067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α-Linolenic Acid Inhibits Receptor Activator of NF-κB Ligand Induced (RANKL-Induced) Osteoclastogenesis and Prevents Inflammatory Bone Loss via Downregulation of Nuclear Factor-KappaB-Inducible Nitric Oxide Synthases (NF-κB-iNOS) Signaling Pathways.
    Song J; Jing Z; Hu W; Yu J; Cui X
    Med Sci Monit; 2017 Oct; 23():5056-5069. PubMed ID: 29061958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anemonin Attenuates RANKL-Induced Osteoclastogenesis and Ameliorates LPS-Induced Inflammatory Bone Loss in Mice
    Hou H; Peng Q; Wang S; Zhang Y; Cao J; Deng Y; Wang Y; Sun WC; Wang HB
    Front Pharmacol; 2019; 10():1696. PubMed ID: 32116686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pueraria lobate Inhibits RANKL-Mediated Osteoclastogenesis Via Downregulation of CREB/PGC1β/c-Fos/NFATc1 Signaling.
    Park KH; Gu DR; Jin SH; Yoon CS; Ko W; Kim YC; Lee SH
    Am J Chin Med; 2017; 45(8):1725-1744. PubMed ID: 29121799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.